UK Prime Minister Boris Johnson has announced a plan for "fast-track visas" to attract scientific talent to the UK post-Brexit, the Financial Times reports.
New UK Prime Minister Boris Johnson has selected his brother Jo Johnson, who is largely liked by researchers, to join the cabinet, Nature News reports.
Nature News examines how science in the UK may fare as Boris Johnson, the next prime minister, pursues Brexit.
The UK Competition and Markets Authority has announced concerns that the $1.2 billion merger will reduce competition for Illumina and could scrutinize it further.
Paul Nurse, the director of the Francis Crick Institute, says British science will suffer if the UK isn't part of Horizon Europe funding scheme, according to the Guardian.
The Campaign for Science and Engineering's Sarah Main writes at the Guardian that increased R&D spending should also come with investment in education.
The Competition and Markets Authority is in charge of promoting competition and reducing anti-competitive activities in the UK.
The project dovetails with a separate effort to sequence the whole exomes of the samples, the first 50,000 of which became available to researchers this month.
The institute — part of the European Molecular Biology Laboratory — said it will use the new funding to increase its computing, storage, and building capacity.
The National Health Service in England is to offer healthy individuals the option of paying to have their genomes analyzed, according to the Guardian.
The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.
The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.
New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.
In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.